Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02267616 · ClinicalTrials.gov registry record · NA
Effectiveness of Prolonged Use of IUD/Implant for Contraception
A NA study of Contraception, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 1,076
- Enrollment target
- 2
- Study locations
NCT02267616: Completed NA study of Contraception, sponsored by Indiana University.
NCT02267616 is a NA study of Contraception that has completed, run by Indiana University. The registered enrollment target is 1,076 participants, above the 440-participant average among 72 other Contraception trials with a reported enrollment target (145% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02267616, a NA study of Contraception, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,076 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will evaluate LNG-IUD and Etonogestrel (ENG) Implant users who are willing to use their contraception beyond the end of the FDA-approved duration. ENG Implant users will also be offered to participate in an arm of the study that will randomize them to either keeping their implant in or having it removed and replaced with a new implant. Participants will be followed for up to three years.
Primary Outcome
Our primary aim is to test the absolute and relative effectiveness of both the LNG-IUD and the ENG implant in a non-inferiority (equivalence) study comparing failure rates of these methods in the 3 years post-FDA approved duration to the failure rates during the first three years.
Conditions Studied
Interventions
- DEVICE Etonogestrel Implant
Study Locations (2)
Indiana
- Indiana University - Indianapolis
Missouri
- Washington University in St. Louis School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,076 participants |
| Start Date | 2011-12 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
What the finished NCT02267616 record still lists
NCT02267616 is an interventional study that assigns participants to a tested intervention. Its 1,076 participants enrollment target places it among the larger protocols in the corpus, above the 440-participant average among 72 other Contraception trials with a reported enrollment target (145% higher).
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Etonogestrel Implant is the first listed.
NCT02267616 reports a single indexed study location in Indiana, Missouri.
Frequently Asked Questions
What is clinical trial NCT02267616 about?
NCT02267616 is a clinical study titled "Effectiveness of Prolonged Use of IUD/Implant for Contraception". This study will evaluate LNG-IUD and Etonogestrel (ENG) Implant users who are willing to use their contraception beyond the end of the FDA-approved duration. ENG Implant users will also be offered to participate in an arm of the study that will randomize them to either keeping their implant in or ha...
What is the current status of trial NCT02267616?
This trial is currently completed. It is a NA study. The enrollment target is 1,076 participants. The study started on 2011-12. Estimated completion is 2021-03-31.
What conditions does trial NCT02267616 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT02267616?
The interventions under investigation include: Etonogestrel Implant (DEVICE).
Who is sponsoring clinical trial NCT02267616?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02267616 being conducted?
This trial has 2 study locations across Indiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02267616's enrollment target sits among peer trials
1,076 8th of 72 higher than 65 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07084883 · 1,076 participants
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
- NCT06658808 · 1,075 participants · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
- NCT06159673 · 1,074 participants · Phase 2
ACP-204 in Adults With Alzheimer's Disease Psychosis
- NCT06074068 · 1,080 participants · NA
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia